Literature DB >> 6662158

Physical exercise and digoxin binding to skeletal muscle: relation to exercise intensity.

T Joreteg, T Jogestrand.   

Abstract

The effect of a 1 h bicycle exercise test on digoxin concentration in skeletal muscle (thigh) and serum was studied in 10 healthy men, who had ingested digoxin 0.5 mg daily for 2 weeks. During maintenance digoxin treatment each subject performed 2 exercise tests, at 70-90 W and 140-180 W both 24 h after the last dose, at a 2-7 day interval. During exercise at the lower work load the mean skeletal muscle digoxin concentration increased by 9% (n.s.) and the mean serum digoxin concentration decreased by 26% (p less than 0.001). The high work load induced a mean increase in skeletal muscle digoxin of 20% (p less than 0.05) and a mean decrease in serum digoxin of 40% (p less than 0.001). The results indicate that the increased uptake of digoxin into exercised skeletal muscle and the decrease in serum digoxin during exercise is related to the intensity of the exercise.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6662158     DOI: 10.1007/bf00542343

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  13 in total

1.  Studies on adrenaline and noradrenaline in human plasma.

Authors:  A VENDSALU
Journal:  Acta Physiol Scand Suppl       Date:  1960

2.  Influence of myocardial mechanical activity and coronary blood flow on myocardial digoxin uptake.

Authors:  B L Lloyd; R R Taylor
Journal:  Cardiovasc Res       Date:  1976-07       Impact factor: 10.787

3.  The effect of insulin and glucose on the myocardial and skeletal muscle uptake of tritiated digoxin in acutely hypokalemic and normokalemic dogs.

Authors:  D J Francis; M E Georoff; B Jackson; F I Marcus
Journal:  J Pharmacol Exp Ther       Date:  1974-03       Impact factor: 4.030

4.  Changes in total plasma content of electrolytes and proteins with maximal exercise.

Authors:  W van Beaumont; J C Strand; J S Petrofsky; S G Hipskind; J E Greenleaf
Journal:  J Appl Physiol       Date:  1973-01       Impact factor: 3.531

5.  Determination of therapeutic and toxic serum digoxin concentrations by radioimmunoassay.

Authors:  T W Smith; V P Butler; E Haber
Journal:  N Engl J Med       Date:  1969-11-27       Impact factor: 91.245

6.  Alteration of the body distribution of tritiated digoxin by acute hyperkalemia in the dog.

Authors:  F I Marcus; G G Kapadia; C Goldsmith
Journal:  J Pharmacol Exp Ther       Date:  1969-01       Impact factor: 4.030

7.  Serum digoxin determination in outpatients--need for standardization.

Authors:  T Jogestrand; R Nordlander
Journal:  Br J Clin Pharmacol       Date:  1983-01       Impact factor: 4.335

8.  The effect of heart rate on myocardial ouabain uptake and on the susceptibility to ouabain cardiotoxicity in the dog.

Authors:  B L Lloyd; R R Taylor
Journal:  Clin Exp Pharmacol Physiol       Date:  1978 Mar-Apr       Impact factor: 2.557

9.  Digoxin concentration in right atrial myocardium, skeletal muscle and serum in man: influence of atrial rhythm.

Authors:  T Jogestrand
Journal:  Eur J Clin Pharmacol       Date:  1980-04       Impact factor: 2.953

10.  The influence of heart rate on digoxin-induced inhibition of myocardial Na+-K+-ATPase activity in the dog.

Authors:  A J Marsh; B L Lloyd; R R Taylor
Journal:  Clin Exp Pharmacol Physiol       Date:  1981 May-Jun       Impact factor: 2.557

View more
  7 in total

Review 1.  Serum concentration monitoring of cardiac glycosides. How helpful is it for adjusting dosage regimens?

Authors:  R J Dobbs; C J O'Neill; A A Deshmukh; P W Nicholson; S M Dobbs
Journal:  Clin Pharmacokinet       Date:  1991-03       Impact factor: 6.447

Review 2.  The influence of cardiovascular physiology on dose/pharmacokinetic and pharmacokinetic/pharmacodynamic relationships.

Authors:  Pietro Fagiolino; Rosa Eiraldi; Marta Vázquez
Journal:  Clin Pharmacokinet       Date:  2006       Impact factor: 6.447

Review 3.  Influence of exercise on the pharmacokinetics of drugs.

Authors:  M A van Baak
Journal:  Clin Pharmacokinet       Date:  1990-07       Impact factor: 6.447

4.  Oral salbutamol decreases serum digoxin concentration.

Authors:  M Edner; T Jogestrand
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

5.  Physical exercise and binding of digoxin to skeletal muscle--effect of muscle activation frequency.

Authors:  T Joreteg; T Jogestrand
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

6.  Pharmacokinetics of the digoxin-quinidine interaction via mixed-effect modelling.

Authors:  P J Williams; J Lane; W Murray; M A Mergener; M Kamigaki
Journal:  Clin Pharmacokinet       Date:  1992-01       Impact factor: 6.447

7.  Oral digoxin effects on exercise performance, K+ regulation and skeletal muscle Na+ ,K+ -ATPase in healthy humans.

Authors:  Simon Sostaric; Aaron C Petersen; Craig A Goodman; Xiaofei Gong; Tai-Juan Aw; Malcolm J Brown; Andrew Garnham; Collene H Steward; Kate T Murphy; Kate A Carey; James Leppik; Steve F Fraser; David Cameron-Smith; Henry Krum; Rodney J Snow; Michael J McKenna
Journal:  J Physiol       Date:  2022-08-02       Impact factor: 6.228

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.